International Flavors & Fragrances (IFF) has been involved in a variety of recent market activities. IFF shares have been sold by several investment firms, including Sumitomo Mitsui Trust Group Inc., ZWJ Investment Counsel Inc., Douglas Lane & Associates LLC and others. IFF's share price experienced a rebound and post-Q3 earnings evaluations recommended varying actions - buy, sell or hold. A valuation check was repeated after a new health claim, portfolio sale, sustainable fragrance expansion, and facility expansion. IFF's share price was adjusted by Barclays and Citigroup, keeping it under close watch. Meanwhile, IFF reported mixed Q4 2025 results, a net loss for full year, a cut to sales price targets, and potential involvement in market manipulation in India. Nevertheless, the company received a consensus recommendation of 'Moderate Buy' and announced developments such as a new LatAm enzyme hub, exploration of science behind well-being, and expanding health claims. Notably, they've secured the first heart health claim for soy protein in Australia and New Zealand.
International Flavors Fragrances IFF News Analytics from Mon, 08 Sep 2025 07:00:00 GMT to Sat, 18 Apr 2026 03:33:45 GMT -
Rating 0
- Innovation 2
- Information 7
- Rumor -3
